Discover the Potential of {4-[(5,6-Diphenyl-2-pyrazinyl)(isopropyl)amino]butoxy}acetic Acid
A critical component in advanced pharmaceutical research and a key player in treating complex conditions.
Get a Quote & SampleProduct Core Value
![{4-[(5,6-Diphenyl-2-pyrazinyl)(isopropyl)amino]butoxy}acetic Acid](https://www.nbinno.com/2025/webimg/gemini_688b1be9307fe_1753947113.png)
{4-[(5,6-Diphenyl-2-pyrazinyl)(isopropyl)amino]butoxy}acetic Acid
This advanced organic compound serves as a potent and selective agonist for the human IP receptor, making it invaluable for pharmaceutical applications. Its long-acting nature and oral availability as a prodrug offer significant advantages in therapeutic development, particularly for conditions like pulmonary arterial hypertension.
- Investigate the crucial role of this chemical in pulmonary arterial hypertension treatment by exploring its efficacy as an IP receptor agonist.
- Source high-quality CAS 475085-57-5 from reliable suppliers to ensure purity and consistency in your research.
- Understand the benefits of using this compound as a selexipag active metabolite in drug development pathways.
- Explore the competitive price of pharmaceutical intermediates to optimize your research and production budgets.
Key Advantages
Enhanced Therapeutic Efficacy
As a potent and selective IP receptor agonist, it offers improved therapeutic outcomes compared to other agonists, directly contributing to better patient care in conditions requiring prostacyclin pathway activation.
Extended Drug Action
The compound's ability to maintain near peak plasma levels for extended periods makes it an ideal candidate for developing long-acting pharmaceutical treatments, reducing the frequency of administration.
Facilitates Targeted Research
Its identification as a selexipag impurity and active metabolite makes it essential for researchers studying drug efficacy, metabolism, and developing new formulations for pulmonary arterial hypertension.
Key Applications
Pulmonary Arterial Hypertension
Crucial for developing advanced treatments for PAH, leveraging its IP receptor agonism for vasodilation and anti-platelet aggregation effects.
Pharmaceutical Research
Serves as a vital tool for studying drug mechanisms, metabolism, and developing novel therapeutic agents in cardiovascular and respiratory diseases.
Chemical Synthesis
A key building block and intermediate in the synthesis of complex organic molecules and potential drug candidates, supporting the fine chemical industry.
Impurity Profiling
Essential for quality control and analytical standards in the pharmaceutical industry, specifically in relation to Selexipag and its metabolites.